ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Large Volume Parenteral (LVP) Market Research Report 2026
Published Date: 2026-03-03
|
Report Code: QYRE-Auto-0L5323
Home | Market Reports
Global Large Volume Parenteral LVP Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Large Volume Parenteral (LVP) Market Research Report 2026

Code: QYRE-Auto-0L5323
Report
2026-03-03
Pages:132
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Baxter Healthcare
B. Braun
Fresenius
Ostuka Pharmaceutical
Beximco Pharma
Albert David
PSI
Ozon Pharmaceuticals
BML Parenteral Drugs
Kelun Group
ICU Medical
SSY Group
Shuang Hor
Cisen Pharmaceutical
PiSA Farmacéutica
Huaren Pharmaceutical
Chimin

Large Volume Parenteral (LVP) Market Size

The global Large Volume Parenteral (LVP) market was valued at US$ 11710 million in 2025 and is anticipated to reach US$ 16150 million by 2032, at a CAGR of 4.8% from 2026 to 2032.

Large Volume Parenteral (LVP) Market

Large Volume Parenteral (LVP) Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Large Volume Parenteral (LVP) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Large volume parenteral preparations or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml, with the most common sizes being 250 ml, 500 ml, 1000 ml, 3000 ml and 5000 ml, with instructions usually recommending large volumes for administration. Parenteral preparations are sterile solid dosage forms or non-pyrogenic liquids containing one or more active ingredients in single-dose or multi-dose containers. They are intended to be administered by infusion, implant or injection into the body.
Global key players of Large Volume Parenteral (LVP) include Baxter Healthcare, Kelun Group, Fresenius, B. Braun, Ostuka Pharmaceutical, etc. The top five players hold a share about 68%. Asia-Pacific is the world's largest market for Large Volume Parenteral (LVP) and holds a share about xx%, followed by Europe and North America, with share about 25% and 24%, separately. In terms of product type, Soft Bag LVP is the largest segment, accounting for a share about 57%. In terms of application, Basic Infusion is the largest field with a share about 63 percent.
This report delivers a comprehensive overview of the global Large Volume Parenteral (LVP) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Large Volume Parenteral (LVP). The Large Volume Parenteral (LVP) market size, estimates, and forecasts are provided in terms of sales volume (Million Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Large Volume Parenteral (LVP) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Large Volume Parenteral (LVP) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Large Volume Parenteral (LVP) Market Report

Report Metric Details
Report Name Large Volume Parenteral (LVP) Market
Accounted market size in 2025 US$ 11710 million
Forecasted market size in 2032 US$ 16150 million
CAGR 4.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Soft Bag LVP
  • Plastic Bottle LVP
  • Glass Bottle LVP
by Application
  • Basic Infusion
  • Therapeutic Infusion
  • Nutritious Infusion
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Baxter Healthcare, Kelun Group, Fresenius, B. Braun, Ostuka Pharmaceutical, ICU Medical, SSY Group, Shuang Hor, Cisen Pharmaceutical, PiSA Farmacéutica, Huaren Pharmaceutical, Chimin, Beximco Pharma, Albert David, PSI Ltd, Ozon Pharmaceuticals, BML Parenteral Drugs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Large Volume Parenteral (LVP) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Large Volume Parenteral (LVP) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Large Volume Parenteral (LVP) Market growing?

Ans: The Large Volume Parenteral (LVP) Market witnessing a CAGR of 4.8% during the forecast period 2026-2032.

What is the Large Volume Parenteral (LVP) Market size in 2032?

Ans: The Large Volume Parenteral (LVP) Market size in 2032 will be US$ 16150 million.

What is the market share of major companies in Large Volume Parenteral (LVP) Market?

Ans: The top five players hold a share about 68%.

What is the Large Volume Parenteral (LVP) Market share by type?

Ans: In terms of product type, Soft Bag LVP is the largest segment, accounting for a share about 57%.

Who are the main players in the Large Volume Parenteral (LVP) Market report?

Ans: The main players in the Large Volume Parenteral (LVP) Market are Baxter Healthcare, Kelun Group, Fresenius, B. Braun, Ostuka Pharmaceutical, ICU Medical, SSY Group, Shuang Hor, Cisen Pharmaceutical, PiSA Farmacéutica, Huaren Pharmaceutical, Chimin, Beximco Pharma, Albert David, PSI Ltd, Ozon Pharmaceuticals, BML Parenteral Drugs

What are the Application segmentation covered in the Large Volume Parenteral (LVP) Market report?

Ans: The Applications covered in the Large Volume Parenteral (LVP) Market report are Basic Infusion, Therapeutic Infusion, Nutritious Infusion

What are the Type segmentation covered in the Large Volume Parenteral (LVP) Market report?

Ans: The Types covered in the Large Volume Parenteral (LVP) Market report are Soft Bag LVP, Plastic Bottle LVP, Glass Bottle LVP

1 Large Volume Parenteral (LVP) Market Overview
1.1 Product Definition
1.2 Large Volume Parenteral (LVP) by Type
1.2.1 Global Large Volume Parenteral (LVP) Market Value by Type: 2025 vs 2032
1.2.2 Soft Bag LVP
1.2.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
1.3 Large Volume Parenteral (LVP) by Application
1.3.1 Global Large Volume Parenteral (LVP) Market Value by Application: 2025 vs 2032
1.3.2 Basic Infusion
1.3.3 Therapeutic Infusion
1.3.4 Nutritious Infusion
1.4 Global Large Volume Parenteral (LVP) Market Size Estimates and Forecasts
1.4.1 Global Large Volume Parenteral (LVP) Revenue 2021–2032
1.4.2 Global Large Volume Parenteral (LVP) Sales 2021–2032
1.4.3 Global Large Volume Parenteral (LVP) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Large Volume Parenteral (LVP) Market Competition by Manufacturers
2.1 Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Large Volume Parenteral (LVP) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Large Volume Parenteral (LVP), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Large Volume Parenteral (LVP), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Large Volume Parenteral (LVP), Product Types and Applications
2.7 Global Key Manufacturers of Large Volume Parenteral (LVP), Date of Entry into the Industry
2.8 Global Large Volume Parenteral (LVP) Market Competitive Situation and Trends
2.8.1 Global Large Volume Parenteral (LVP) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Large Volume Parenteral (LVP) Players Market Share by Revenue
2.8.3 Global Large Volume Parenteral (LVP) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Large Volume Parenteral (LVP) Market Scenario by Region
3.1 Global Large Volume Parenteral (LVP) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Large Volume Parenteral (LVP) Sales by Region: 2021–2032
3.2.1 Global Large Volume Parenteral (LVP) Sales by Region: 2021–2026
3.2.2 Global Large Volume Parenteral (LVP) Sales by Region: 2027–2032
3.3 Global Large Volume Parenteral (LVP) Revenue by Region: 2021–2032
3.3.1 Global Large Volume Parenteral (LVP) Revenue by Region: 2021–2026
3.3.2 Global Large Volume Parenteral (LVP) Revenue by Region: 2027–2032
3.4 North America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.4.1 North America Large Volume Parenteral (LVP) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Large Volume Parenteral (LVP) Sales by Country (2021–2032)
3.4.3 North America Large Volume Parenteral (LVP) Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.5.1 Europe Large Volume Parenteral (LVP) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Large Volume Parenteral (LVP) Sales by Country (2021–2032)
3.5.3 Europe Large Volume Parenteral (LVP) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Large Volume Parenteral (LVP) Market Facts & Figures by Region
3.6.1 Asia Pacific Large Volume Parenteral (LVP) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2021–2032)
3.6.3 Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.7.1 Latin America Large Volume Parenteral (LVP) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Large Volume Parenteral (LVP) Sales by Country (2021–2032)
3.7.3 Latin America Large Volume Parenteral (LVP) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.8.1 Middle East and Africa Large Volume Parenteral (LVP) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Large Volume Parenteral (LVP) Sales by Type (2021–2032)
4.1.1 Global Large Volume Parenteral (LVP) Sales by Type (2021–2026)
4.1.2 Global Large Volume Parenteral (LVP) Sales by Type (2027–2032)
4.1.3 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2021–2032)
4.2 Global Large Volume Parenteral (LVP) Revenue by Type (2021–2032)
4.2.1 Global Large Volume Parenteral (LVP) Revenue by Type (2021–2026)
4.2.2 Global Large Volume Parenteral (LVP) Revenue by Type (2027–2032)
4.2.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2021–2032)
4.3 Global Large Volume Parenteral (LVP) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Large Volume Parenteral (LVP) Sales by Application (2021–2032)
5.1.1 Global Large Volume Parenteral (LVP) Sales by Application (2021–2026)
5.1.2 Global Large Volume Parenteral (LVP) Sales by Application (2027–2032)
5.1.3 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2021–2032)
5.2 Global Large Volume Parenteral (LVP) Revenue by Application (2021–2032)
5.2.1 Global Large Volume Parenteral (LVP) Revenue by Application (2021–2026)
5.2.2 Global Large Volume Parenteral (LVP) Revenue by Application (2027–2032)
5.2.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2021–2032)
5.3 Global Large Volume Parenteral (LVP) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Baxter Healthcare
6.1.1 Baxter Healthcare Company Information
6.1.2 Baxter Healthcare Description and Business Overview
6.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio
6.1.5 Baxter Healthcare Recent Developments/Updates
6.2 Kelun Group
6.2.1 Kelun Group Company Information
6.2.2 Kelun Group Description and Business Overview
6.2.3 Kelun Group Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Kelun Group Large Volume Parenteral (LVP) Product Portfolio
6.2.5 Kelun Group Recent Developments/Updates
6.3 Fresenius
6.3.1 Fresenius Company Information
6.3.2 Fresenius Description and Business Overview
6.3.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Fresenius Large Volume Parenteral (LVP) Product Portfolio
6.3.5 Fresenius Recent Developments/Updates
6.4 B. Braun
6.4.1 B. Braun Company Information
6.4.2 B. Braun Description and Business Overview
6.4.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 B. Braun Large Volume Parenteral (LVP) Product Portfolio
6.4.5 B. Braun Recent Developments/Updates
6.5 Ostuka Pharmaceutical
6.5.1 Ostuka Pharmaceutical Company Information
6.5.2 Ostuka Pharmaceutical Description and Business Overview
6.5.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
6.5.5 Ostuka Pharmaceutical Recent Developments/Updates
6.6 ICU Medical
6.6.1 ICU Medical Company Information
6.6.2 ICU Medical Description and Business Overview
6.6.3 ICU Medical Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 ICU Medical Large Volume Parenteral (LVP) Product Portfolio
6.6.5 ICU Medical Recent Developments/Updates
6.7 SSY Group
6.7.1 SSY Group Company Information
6.7.2 SSY Group Description and Business Overview
6.7.3 SSY Group Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 SSY Group Large Volume Parenteral (LVP) Product Portfolio
6.7.5 SSY Group Recent Developments/Updates
6.8 Shuang Hor
6.8.1 Shuang Hor Company Information
6.8.2 Shuang Hor Description and Business Overview
6.8.3 Shuang Hor Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Shuang Hor Large Volume Parenteral (LVP) Product Portfolio
6.8.5 Shuang Hor Recent Developments/Updates
6.9 Cisen Pharmaceutical
6.9.1 Cisen Pharmaceutical Company Information
6.9.2 Cisen Pharmaceutical Description and Business Overview
6.9.3 Cisen Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Cisen Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
6.9.5 Cisen Pharmaceutical Recent Developments/Updates
6.10 PiSA Farmacéutica
6.10.1 PiSA Farmacéutica Company Information
6.10.2 PiSA Farmacéutica Description and Business Overview
6.10.3 PiSA Farmacéutica Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 PiSA Farmacéutica Large Volume Parenteral (LVP) Product Portfolio
6.10.5 PiSA Farmacéutica Recent Developments/Updates
6.11 Huaren Pharmaceutical
6.11.1 Huaren Pharmaceutical Company Information
6.11.2 Huaren Pharmaceutical Description and Business Overview
6.11.3 Huaren Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Huaren Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
6.11.5 Huaren Pharmaceutical Recent Developments/Updates
6.12 Chimin
6.12.1 Chimin Company Information
6.12.2 Chimin Description and Business Overview
6.12.3 Chimin Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Chimin Large Volume Parenteral (LVP) Product Portfolio
6.12.5 Chimin Recent Developments/Updates
6.13 Beximco Pharma
6.13.1 Beximco Pharma Company Information
6.13.2 Beximco Pharma Description and Business Overview
6.13.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio
6.13.5 Beximco Pharma Recent Developments/Updates
6.14 Albert David
6.14.1 Albert David Company Information
6.14.2 Albert David Description and Business Overview
6.14.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Albert David Large Volume Parenteral (LVP) Product Portfolio
6.14.5 Albert David Recent Developments/Updates
6.15 PSI Ltd
6.15.1 PSI Ltd Company Information
6.15.2 PSI Ltd Description and Business Overview
6.15.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 PSI Ltd Large Volume Parenteral (LVP) Product Portfolio
6.15.5 PSI Ltd Recent Developments/Updates
6.16 Ozon Pharmaceuticals
6.16.1 Ozon Pharmaceuticals Company Information
6.16.2 Ozon Pharmaceuticals Description and Business Overview
6.16.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio
6.16.5 Ozon Pharmaceuticals Recent Developments/Updates
6.17 BML Parenteral Drugs
6.17.1 BML Parenteral Drugs Company Information
6.17.2 BML Parenteral Drugs Description and Business Overview
6.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio
6.17.5 BML Parenteral Drugs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Large Volume Parenteral (LVP) Industry Chain Analysis
7.2 Large Volume Parenteral (LVP) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Large Volume Parenteral (LVP) Production Mode & Process Analysis
7.4 Large Volume Parenteral (LVP) Sales and Marketing
7.4.1 Large Volume Parenteral (LVP) Sales Channels
7.4.2 Large Volume Parenteral (LVP) Distributors
7.5 Large Volume Parenteral (LVP) Customer Analysis
8 Large Volume Parenteral (LVP) Market Dynamics
8.1 Large Volume Parenteral (LVP) Industry Trends
8.2 Large Volume Parenteral (LVP) Market Drivers
8.3 Large Volume Parenteral (LVP) Market Challenges
8.4 Large Volume Parenteral (LVP) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Baxter Healthcare
B. Braun
Fresenius
Ostuka Pharmaceutical
Beximco Pharma
Albert David
PSI
Ozon Pharmaceuticals
BML Parenteral Drugs
Kelun Group
ICU Medical
SSY Group
Shuang Hor
Cisen Pharmaceutical
PiSA Farmacéutica
Huaren Pharmaceutical
Chimin
List of Tables
 Table 1. Global Large Volume Parenteral (LVP) Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Large Volume Parenteral (LVP) Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Large Volume Parenteral (LVP) Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Large Volume Parenteral (LVP) Sales (Million Units) of Key Manufacturers (2021–2026)
 Table 5. Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Large Volume Parenteral (LVP) Average Price (US$/K Units) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Large Volume Parenteral (LVP), Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Large Volume Parenteral (LVP), Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Large Volume Parenteral (LVP), Product Types and Applications
 Table 12. Global Key Manufacturers of Large Volume Parenteral (LVP), Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Large Volume Parenteral (LVP) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Large Volume Parenteral (LVP) Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Large Volume Parenteral (LVP) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Large Volume Parenteral (LVP) Sales by Region (Million Units), 2021–2026
 Table 18. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2021–2026)
 Table 19. Global Large Volume Parenteral (LVP) Sales by Region (Million Units), 2027–2032
 Table 20. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2027–2032)
 Table 21. Global Large Volume Parenteral (LVP) Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2021–2026)
 Table 23. Global Large Volume Parenteral (LVP) Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2027–2032)
 Table 25. North America Large Volume Parenteral (LVP) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Large Volume Parenteral (LVP) Sales by Country (Million Units), 2021–2026
 Table 27. North America Large Volume Parenteral (LVP) Sales by Country (Million Units), 2027–2032
 Table 28. North America Large Volume Parenteral (LVP) Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Large Volume Parenteral (LVP) Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Large Volume Parenteral (LVP) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Large Volume Parenteral (LVP) Sales by Country (Million Units), 2021–2026
 Table 32. Europe Large Volume Parenteral (LVP) Sales by Country (Million Units), 2027–2032
 Table 33. Europe Large Volume Parenteral (LVP) Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Large Volume Parenteral (LVP) Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Large Volume Parenteral (LVP) Sales by Region (Million Units), 2021–2026
 Table 37. Asia Pacific Large Volume Parenteral (LVP) Sales by Region (Million Units), 2027–2032
 Table 38. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Large Volume Parenteral (LVP) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Large Volume Parenteral (LVP) Sales by Country (Million Units), 2021–2026
 Table 42. Latin America Large Volume Parenteral (LVP) Sales by Country (Million Units), 2027–2032
 Table 43. Latin America Large Volume Parenteral (LVP) Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Large Volume Parenteral (LVP) Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (Million Units), 2021–2026
 Table 47. Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (Million Units), 2027–2032
 Table 48. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Large Volume Parenteral (LVP) Sales (Million Units) by Type (2021–2026)
 Table 51. Global Large Volume Parenteral (LVP) Sales (Million Units) by Type (2027–2032)
 Table 52. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2021–2026)
 Table 53. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2027–2032)
 Table 54. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2021–2026)
 Table 57. Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2027–2032)
 Table 58. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Type (2021–2026)
 Table 59. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Type (2027–2032)
 Table 60. Global Large Volume Parenteral (LVP) Sales (Million Units) by Application (2021–2026)
 Table 61. Global Large Volume Parenteral (LVP) Sales (Million Units) by Application (2027–2032)
 Table 62. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2021–2026)
 Table 63. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2027–2032)
 Table 64. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2021–2026)
 Table 67. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2027–2032)
 Table 68. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Application (2021–2026)
 Table 69. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Application (2027–2032)
 Table 70. Baxter Healthcare Company Information
 Table 71. Baxter Healthcare Description and Business Overview
 Table 72. Baxter Healthcare Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 73. Baxter Healthcare Large Volume Parenteral (LVP) Product
 Table 74. Baxter Healthcare Recent Developments/Updates
 Table 75. Kelun Group Company Information
 Table 76. Kelun Group Description and Business Overview
 Table 77. Kelun Group Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 78. Kelun Group Large Volume Parenteral (LVP) Product
 Table 79. Kelun Group Recent Developments/Updates
 Table 80. Fresenius Company Information
 Table 81. Fresenius Description and Business Overview
 Table 82. Fresenius Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 83. Fresenius Large Volume Parenteral (LVP) Product
 Table 84. Fresenius Recent Developments/Updates
 Table 85. B. Braun Company Information
 Table 86. B. Braun Description and Business Overview
 Table 87. B. Braun Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 88. B. Braun Large Volume Parenteral (LVP) Product
 Table 89. B. Braun Recent Developments/Updates
 Table 90. Ostuka Pharmaceutical Company Information
 Table 91. Ostuka Pharmaceutical Description and Business Overview
 Table 92. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 93. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product
 Table 94. Ostuka Pharmaceutical Recent Developments/Updates
 Table 95. ICU Medical Company Information
 Table 96. ICU Medical Description and Business Overview
 Table 97. ICU Medical Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 98. ICU Medical Large Volume Parenteral (LVP) Product
 Table 99. ICU Medical Recent Developments/Updates
 Table 100. SSY Group Company Information
 Table 101. SSY Group Description and Business Overview
 Table 102. SSY Group Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 103. SSY Group Large Volume Parenteral (LVP) Product
 Table 104. SSY Group Recent Developments/Updates
 Table 105. Shuang Hor Company Information
 Table 106. Shuang Hor Description and Business Overview
 Table 107. Shuang Hor Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 108. Shuang Hor Large Volume Parenteral (LVP) Product
 Table 109. Shuang Hor Recent Developments/Updates
 Table 110. Cisen Pharmaceutical Company Information
 Table 111. Cisen Pharmaceutical Description and Business Overview
 Table 112. Cisen Pharmaceutical Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 113. Cisen Pharmaceutical Large Volume Parenteral (LVP) Product
 Table 114. Cisen Pharmaceutical Recent Developments/Updates
 Table 115. PiSA Farmacéutica Company Information
 Table 116. PiSA Farmacéutica Description and Business Overview
 Table 117. PiSA Farmacéutica Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 118. PiSA Farmacéutica Large Volume Parenteral (LVP) Product
 Table 119. PiSA Farmacéutica Recent Developments/Updates
 Table 120. Huaren Pharmaceutical Company Information
 Table 121. Huaren Pharmaceutical Description and Business Overview
 Table 122. Huaren Pharmaceutical Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 123. Huaren Pharmaceutical Large Volume Parenteral (LVP) Product
 Table 124. Huaren Pharmaceutical Recent Developments/Updates
 Table 125. Chimin Company Information
 Table 126. Chimin Description and Business Overview
 Table 127. Chimin Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 128. Chimin Large Volume Parenteral (LVP) Product
 Table 129. Chimin Recent Developments/Updates
 Table 130. Beximco Pharma Company Information
 Table 131. Beximco Pharma Description and Business Overview
 Table 132. Beximco Pharma Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 133. Beximco Pharma Large Volume Parenteral (LVP) Product
 Table 134. Beximco Pharma Recent Developments/Updates
 Table 135. Albert David Company Information
 Table 136. Albert David Description and Business Overview
 Table 137. Albert David Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 138. Albert David Large Volume Parenteral (LVP) Product
 Table 139. Albert David Recent Developments/Updates
 Table 140. PSI Ltd Company Information
 Table 141. PSI Ltd Description and Business Overview
 Table 142. PSI Ltd Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 143. PSI Ltd Large Volume Parenteral (LVP) Product
 Table 144. PSI Ltd Recent Developments/Updates
 Table 145. Ozon Pharmaceuticals Company Information
 Table 146. Ozon Pharmaceuticals Description and Business Overview
 Table 147. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 148. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product
 Table 149. Ozon Pharmaceuticals Recent Developments/Updates
 Table 150. BML Parenteral Drugs Company Information
 Table 151. BML Parenteral Drugs Description and Business Overview
 Table 152. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (Million Units), Revenue (US$ Million), Price (US$/K Units), and Gross Margin (2021–2026)
 Table 153. BML Parenteral Drugs Large Volume Parenteral (LVP) Product
 Table 154. BML Parenteral Drugs Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Large Volume Parenteral (LVP) Distributors List
 Table 158. Large Volume Parenteral (LVP) Customers List
 Table 159. Large Volume Parenteral (LVP) Market Trends
 Table 160. Large Volume Parenteral (LVP) Market Drivers
 Table 161. Large Volume Parenteral (LVP) Market Challenges
 Table 162. Large Volume Parenteral (LVP) Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Large Volume Parenteral (LVP)
 Figure 2. Global Large Volume Parenteral (LVP) Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Large Volume Parenteral (LVP) Market Share by Type: 2025 & 2032
 Figure 4. Soft Bag LVP Product Picture
 Figure 5. Plastic Bottle LVP Product Picture
 Figure 6. Glass Bottle LVP Product Picture
 Figure 7. Global Large Volume Parenteral (LVP) Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Large Volume Parenteral (LVP) Market Share by Application: 2025 & 2032
 Figure 9. Basic Infusion
 Figure 10. Therapeutic Infusion
 Figure 11. Nutritious Infusion
 Figure 12. Global Large Volume Parenteral (LVP) Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Large Volume Parenteral (LVP) Market Size (US$ Million), 2021–2032
 Figure 14. Global Large Volume Parenteral (LVP) Sales (Million Units), 2021–2032
 Figure 15. Global Large Volume Parenteral (LVP) Average Price (US$/K Units), 2021–2032
 Figure 16. Large Volume Parenteral (LVP) Report Years Considered
 Figure 17. Large Volume Parenteral (LVP) Sales Share by Manufacturers in 2025
 Figure 18. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Large Volume Parenteral (LVP) Players: Market Share by Revenue in Large Volume Parenteral (LVP) in 2025
 Figure 20. Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Large Volume Parenteral (LVP) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Large Volume Parenteral (LVP) Sales Market Share by Country (2021–2032)
 Figure 23. North America Large Volume Parenteral (LVP) Revenue Market Share by Country (2021–2032)
 Figure 24. U.S. Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Large Volume Parenteral (LVP) Sales Market Share by Country (2021–2032)
 Figure 27. Europe Large Volume Parenteral (LVP) Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Large Volume Parenteral (LVP) Revenue Market Share by Region (2021–2032)
 Figure 35. China Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Large Volume Parenteral (LVP) Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Large Volume Parenteral (LVP) Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Large Volume Parenteral (LVP) Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Large Volume Parenteral (LVP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Large Volume Parenteral (LVP) by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Large Volume Parenteral (LVP) by Type (2021–2032)
 Figure 56. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Large Volume Parenteral (LVP) by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Large Volume Parenteral (LVP) by Application (2021–2032)
 Figure 59. Global Large Volume Parenteral (LVP) Price (US$/K Units) by Application (2021–2032)
 Figure 60. Large Volume Parenteral (LVP) Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Large Volume Parenteral Preparations Market Research Report 2025
Global Large Volume Parenteral Product Market Research Report 2025
Global Large Volume Parenteral Non PVC Bag Market Research Report 2025
Global Parenteral Drugs Market Research Report 2024
Global Small Volume Parenterals SVP Market Insights Forecast to 2030
Global Non LVP Parenterals Products Market Insights Forecast to 2030
Large Volume Intravenous Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Large Volume Parenteral Light Inspection Machine Market Research Report 2024
Global Large Volume Injector Market Research Report 2024
Global Large Volume Wearable Injectors Market Insights Forecast to 2030
Global Ultra large Volume Wearable Injectors Market Research Report 2024
Global Intravenous Solutions Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global IV Electrolyte Solutions Market Research Report 2024
Global Small Volume Saline Market Research Report 2024
Global Volume Expander Market Research Report 2025
Global Parenteral Formula Market Research Report 2024
Global I V Intravenous Fluid Bags Market Research Report 2024
High Volume Dispensing Systems Market
Global Sterile Intravenous IV Solution Market Insights Forecast to 2030
Global Parenteral Excipients Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions